Patent ID: 8518975
Filing Date: 2013-08-27
Classification: A61P,C07D

Abstract:
1. A compound of the formula (I): or a pharmaceutically acceptable salt or ester, thereof, wherein: (A) in the ring in formula (I) is a reference letter to identify the ring; the numbers (1), (2), (3), (4), and (5) are reference numbers to identify positions of the Ring (A); the dotted line ( f is 1; n is 1 to 5; q is 0, 1 or 2, and each q is independently selected; r is 1 to 3 ; t is 1 or 2; W is selected from the group consisting of: —C(O)—, and —C(═NR the moiety -G-R G is selected from the group consisting of: a direct bond, —C(O)—, —(C═NR G q for the —C(R G (a) q for the —C(R (b) G G G R R R Each R Each R R R R Each R two R R R Each R Each R (a) when no —SF (b) When W is C(═O), and G (c) When W is C(═O), and G